The U.S. Food and Drug Administration (FDA) sent a letter to cardiologists this week to explain its evaluation of...
Hemodynamic Support Devices
This hemodynamic support systems include intra-aortic balloon pumps (IABP), percutaneous ventricular assist devices (pVAD) like the Impella or tandemheart, and ventricular assist devices (VAD).
The Abiomed Impella RP had higher than expected mortality in its post-approval study, much higher than in its pre-market approval study. The vendor and the FDA believe this might be due to poor patient selection and implanting the device too late to aid the patient.
Feature | Hemodynamic Support Devices | February 05, 2019 | Dave Fornell, Editor
The startup company Genetesis introduced a new cardiac imaging modality it calls magnetocardiography. The scanner creates images from the biomagnetic activity of the heart, using the polarization and depolarization of the heart during the cardiac cycle.
Feature | AHA | January 14, 2019 | Dave Fornell, Editor
Here are a few of the takeaways from the clinical studies presented and new technology shown on the exhibit floor at...
Sponsored Content | Videos | January 10, 2019
...
Sponsored Content | Videos | Hemodynamic Support Devices | December 13, 2018
A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.
News | Cardiovascular Surgery | December 11, 2018
December 11, 2018 — The scientific journal...
News | Intra-Aortic Balloon Pumps (IABP) | November 05, 2018
November 5, 2018 — The U.S. Food and Drug Administration (FDA) is evaluating recent reports of Getinge's Maquet/...
Sponsored Content | Videos | Cath Lab | October 24, 2018
A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.
Feature | Heart Failure | October 19, 2018
October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U....
News | Intra-Aortic Balloon Pumps (IABP) | September 24, 2018
Getinge Issues Worldwide Voluntary Correction of Maquet/Getinge Cardiosave Intra-Aortic Balloon Pump
September 24, 2018 — Getinge is voluntarily initiating a worldwide recall involving a field correction of...
News | Hemodynamic Support Devices | September 20, 2018
September 19, 2018 — Abiomed Inc. announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ)...
Videos | Hemodynamic Support Devices | August 31, 2018
Behnam Tehrani, M.D., FSCAI, director of the cardiac cath lab, INOVA Heart and Vascular Institute, Fairfax, Va.,...
Technology | Ventricular Assist Devices (VAD) | July 17, 2018
July 17, 2018 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive...
